HopeStage
Back to all studies
RecruitingNCT06269627

Acamprosate or placebo: brain electrical activity during alcohol-use treatment

About this titleRead the official source — NCT06269627
Medication studyAges 21–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

What will I do during this study?

After a detoxification period of about seven days, participants stay in the clinic for 21 days. They are randomly assigned to acamprosate or placebo (an inactive comparison treatment), taken as two capsules three times a day. EEG (recording of the brain’s electrical activity) recordings and anxiety and craving assessments are completed before and after the treatment period.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 7, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
48
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT06269627
Official title
Show the full official title

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

Recruitment & locations

Currently recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Acamprosate calcium.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies